Chandan Healthcare Ltd
Incorporated in September 2003, Chandan Healthcare Limited runs diagnostic centers in North India with pathology and radiology testing services.[1]
- Market Cap ₹ 514 Cr.
- Current Price ₹ 210
- High / Low ₹ 358 / 185
- Stock P/E 19.5
- Book Value ₹ 69.9
- Dividend Yield 0.00 %
- ROCE 23.1 %
- ROE 13.2 %
- Face Value ₹ 10.0
Pros
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Debtor days have increased from 82.4 to 114 days.
- Working capital days have increased from 61.8 days to 111 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Healthcare Service Provider
Part of Nifty SME Emerge
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|
| 120 | 137 | 177 | 230 | 276 | 289 | |
| 117 | 128 | 150 | 189 | 219 | 232 | |
| Operating Profit | 2 | 9 | 26 | 41 | 57 | 57 |
| OPM % | 1.9% | 7% | 15% | 18% | 21% | 20% |
| 0 | 0 | 1 | 2 | 4 | 3 | |
| Interest | 2 | 2 | 3 | 5 | 14 | 9 |
| Depreciation | 2 | 2 | 3 | 7 | 15 | 13 |
| Profit before tax | -1 | 5 | 21 | 32 | 32 | 37 |
| Tax % | 3% | 28% | 24% | 27% | 37% | |
| -1 | 3 | 16 | 24 | 20 | 25 | |
| EPS in Rs | -0.56 | 1.68 | 8.14 | 9.07 | 7.93 | 10.12 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 26% |
| TTM: | 20% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 79% |
| TTM: | -12% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | -8% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 19% |
| 3 Years: | 22% |
| Last Year: | 13% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Equity Capital | 20 | 20 | 20 | 24 | 24 |
| Reserves | 4 | 7 | 21 | 98 | 147 |
| 17 | 21 | 36 | 48 | 54 | |
| 41 | 49 | 41 | 40 | 65 | |
| Total Liabilities | 82 | 98 | 118 | 211 | 290 |
| 29 | 33 | 48 | 76 | 101 | |
| CWIP | 0 | 0 | 0 | 4 | 12 |
| Investments | 6 | 7 | 3 | 1 | 20 |
| 46 | 58 | 66 | 129 | 156 | |
| Total Assets | 82 | 98 | 118 | 211 | 290 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| 6 | 4 | 1 | -29 | 16 | |
| -11 | -6 | -15 | -36 | -40 | |
| 3 | 2 | 16 | 67 | 21 | |
| Net Cash Flow | -1 | 0 | 2 | 2 | -3 |
| Free Cash Flow | -1 | -1 | -18 | -68 | -26 |
| CFO/OP | 275% | 60% | 23% | -50% | 45% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Debtor Days | 88 | 63 | 59 | 74 | 114 |
| Inventory Days | 46 | 71 | 96 | 126 | 92 |
| Days Payable | 185 | 251 | 102 | 102 | 112 |
| Cash Conversion Cycle | -51 | -117 | 53 | 98 | 95 |
| Working Capital Days | -11 | -21 | -1 | 75 | 111 |
| ROCE % | 16% | 37% | 29% | 23% |
Insights
In beta| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Number of Collection Centers count ・Standalone data |
|
||||
| Number of Diagnostic Centers & Labs count ・Standalone data |
|||||
| Pathology Revenue Share % |
|||||
| Total Tests Conducted Lakhs ・Standalone data |
|||||
| B2C (Retail Diagnostics) Revenue Share % ・Standalone data |
|||||
| B2G (Government PPPs) Revenue Share % ・Standalone data |
|||||
| Total Patient Count Lakhs ・Standalone data |
|||||
| Number of Franchise Centers count ・Standalone data |
|||||
Extracted by Screener AI
Documents
Announcements
-
Copy of Newspaper Publication
- Newspaper advertisement published for 23rd AGM notice and e-voting instructions on 09 September 2026.
-
Shareholders meeting
- Submitted FY2025-26 annual report and AGM notice; 23rd AGM on 30 September 2026 at 4:00 PM via VC.
-
Outcome of Board Meeting
- Board recommended appointing Sanjay Srivastava as independent director and reallocated ₹50 crore warrant proceeds for new diagnostic centres.
-
Analysts/Institutional Investor Meet/Con. Call Updates
- Investor/analyst group meeting scheduled virtually on September 11, 2026 at 1:00 P.M. IST.
-
Clarification - Financial Results
- Exchange has sought clarification from Chandan Healthcare Limited for the quarter ended 30-Jun-2026 with respect to Regulation 33 of the SEBI (LODR) Regulations, 2015. On …
Concalls
-
Aug 2026Transcript PPT REC
-
Jun 2026Transcript PPT REC
-
Feb 2026Transcript PPT
-
Dec 2025Transcript PPT
-
Nov 2025TranscriptPPT REC
-
Aug 2025TranscriptAI SummaryPPT
Business Profile[1]
Chandan Healthcare Limited operates a diagnostic network in North India that offers pathology and radiology testing services. The company has a presence in Uttar Pradesh, Uttarakhand, and Jaipur (Rajasthan), with a strong network of labs, satellite centers, and collection points.